Inventor
ABHIJIT DANDAPAT
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C12NMicroorganisms or enzymes27%
C07KPeptides23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
12,473,348Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cells202512,473,347Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cells202512,435,122Fc-epsilon CAR202512,403,178Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)202512,221,629Methods for producing fibroadipogenic progenitor cells202512,215,356Methods of preparing a primary cell sample202511,813,292Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)202311,643,452Fc-epsilon car202311,591,573Methods of preparing a primary cell sample2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to IMMUNITYBIO INC (6)· patent assignee history
2023–2025Patents assigned to CELCUITY INC (2)· patent assignee history
2023Patents assigned to IMMUNITY BIO INC (1)· patent assignee history
2023–2025Based in US· patent location history
2025Patents assigned to UNIV MINNESOTA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNITYBIO INC | 6 | 2023–2025 |
| CELCUITY INC | 2 | 2023–2025 |
| IMMUNITY BIO INC | 1 | 2023 |
| UNIV MINNESOTA | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2023–2025 |